N. Rohwer
Cancer Research · 2011
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Cancer Research — 33 citations into it; #1,366 of 1,780 by trust here, #1,595 by citations
- Molecular Biology — 30 citations into it
Whom N. Rohwer trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts N. Rohwer overall
Papers from N. Rohwer's perspective
Ordered by how strongly the researchers N. Rohwer trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- Why do cancers have high aerobic glycolysis? (Nature Reviews. Cancer)
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. (Cancer Cell)
- Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. (Cell Metabolism)
- Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation (Molecular and Cellular Biology)
- Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. (Cancer Cell)
- HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing (Science)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)